How Microgravity Affects the Biology of Living SystemsView this Special Issue
Research Article | Open Access
Valeria Gasperi, Cinzia Rapino, Natalia Battista, Monica Bari, Nicolina Mastrangelo, Silvia Angeletti, Enrico Dainese, Mauro Maccarrone, "A Functional Interplay between 5-Lipoxygenase and μ-Calpain Affects Survival and Cytokine Profile of Human Jurkat T Lymphocyte Exposed to Simulated Microgravity", BioMed Research International, vol. 2014, Article ID 782390, 10 pages, 2014. https://doi.org/10.1155/2014/782390
A Functional Interplay between 5-Lipoxygenase and μ-Calpain Affects Survival and Cytokine Profile of Human Jurkat T Lymphocyte Exposed to Simulated Microgravity
A growing body of evidence strongly indicates that both simulated and authentic weightlessness exert a broad range of effects on mammalian tissues and cells, including impairment of immune cell function and increased apoptotic death. We previously reported that microgravity-dependent activation of 5-lipoxygenase (5-LOX) might play a central role in the initiation of apoptosis in human T lymphocytes, suggesting that the upregulation of this enzyme might be (at least in part) responsible for immunodepression observed in astronauts during space flights. Herein, we supplement novel information about the molecular mechanisms underlying microgravity-triggered apoptotic cell death and immune system deregulation, demonstrating that under simulated microgravity human Jurkat T cells increase the content of cytosolic DNA fragments and cytochrome c (typical hallmarks of apoptosis) and have an upregulated expression and activity of µ-calpain. These events were paralleled by the unbalance of interleukin- (IL-) 2 and interferon- (INF-) γ, anti- and proapoptotic cytokines, respectively, that seemed to be dependent on the functional interplay between 5-LOX and µ-calpain. Indeed, we report unprecedented evidence that 5-LOX inhibition reduced apoptotic death, restored the initial IL-2/INF-γ ratio, and more importantly reverted µ-calpain activation induced by simulated microgravity.
Several studies have shown that authentic space conditions markedly alter physiological processes, thus leading to cardiovascular changes , loss of bone density [2, 3], muscle atrophy [2, 4], and immunodepression [5, 6]. To date, it is well established that cells of the immune system are severely affected by microgravity conditions [5–8]. In particular, alterations observed in astronauts and rodents flown in space included altered distribution and function of circulating leukocytes [9–11], lymphocytopenia [12–14], and impaired T cell activation [9, 14–16]. In addition, several in vivo and in vitro studies reported a weightlessness-dependent alteration of cytokine secretion from T-helper 1 (Th1) and T-helper 2 (Th2) cells that in turn results in a deregulation of cell-to-cell crosstalk as well as of inflammatory responses [9–11, 17].
It has been reported that several proinflammatory Th1 cytokines, including interferon- (INF-) γ, tumor necrosis factor- (TNF-) β and interleukin- (IL-) 2, and anti-inflammatory Th2 cytokines like IL-4 and IL-10, as well as leukaemia inhibitory factor (LIF), are related to programmed cell death (PCD). These glycoproteins, indeed, are able to induce or protect cells from apoptosis [18–23], so that an alternative classification distinguishes them as anti-(LIF, IL-2, IL-4, IL-10) or proapoptotic (INF-γ) substances. A hot topic is the study of the effect of microgravity (be it real or simulated) on apoptosis of different mammalian cell types, including cerebral vascular smooth muscle , thyroid cancer , endothelial cells , cultured glial cells , spermatozoa , B lymphocytes , and T cells [6, 30]. In particular, 5-lipoxygenase (5-LOX) has been proposed as a “gravity responder,” which executes the apoptotic events induced by microgravity in human lymphocytes [6, 30].
Evidence is accumulating that the execution of PCD is finely regulated by a distinct set of signal transduction pathways and catabolic mechanisms (e.g., mitochondrial, lysosomal, and nuclear alterations, lipid modifications, and cytosolic calcium accumulation), and recent data provided first hints that lipid hydroperoxides impact on PCD . Indeed, LOX-catalyzed lipid peroxidation has been reported to be a specific downstream event that triggers apoptosis-inducing factor- (AIF) mediated PCD in primary neurons in culture and in mice . In the same context, calpains cleave multiple substrates potentially involved in PCD and including cyclin-dependent kinase-5 , plasma membrane Ca2+ ATPase isoform-1 , and calcineurin . Also AIF is a calpain substrate implicated in neuronal death, because its proteolysis activates PCD through a translocation of AIF itself from the mitochondria to the nucleus [35, 36].
Against this background, the present study aimed at better defining the influence of the space environment on survival and cytokine profile of human lymphocytes, in order to identify a possible link between these events. In this context, we report an unprecedented functional interplay between 5-LOX and μ-calpain in modulating PCD induced by simulated microgravity.
2. Materials and Methods
Chemicals were of the purest analytical grade. Human recombinants IL-2, IL-4, IL-6, IL-10, INF-γ, and LIF, calpain substrate [N-Suc-Leu-Tyr-AMC (7-amido-4-methyl-coumarin)], AA861 (specific inhibitor of 5-LOX), and E64D (specific inhibitor of calpain) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Mouse anti-cytochrome c antibody was from Cell Signalling Technology Inc. (Danvers, MA, USA); mouse anti-calpain-1 was from Calbiochem (Merck Darmstadt, Germany). Rabbit anti-LIF, anti-IL-2, anti-IL-4, anti-IL-6, anti-IL-10, anti-INF-γ, secondary antibodies conjugated to horseradish peroxidase (HRP), and enhanced chemiluminescence (ECL) kit were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Goat anti-rabbit conjugated to alkaline phosphatase (GAR-AP) was from Bio-Rad (Hercules, CA, USA).
2.2. Simulated Microgravity Cell Cultures
To simulate space conditions, the rotary cell culture system (RCCS), developed by the National Aeronautics and Space Administration (Washington, DC, USA) and manufactured by Synthecon (Houston, TX, USA), was used. Human Jurkat T cells (Clone E6-1) (ATCC, Manassas, VA, USA) were grown in RPMI 1640 medium supplemented with 2 mM glutamine, 2.5 mM sodium pyruvate, 100 U/mL penicillin, 100 μg/mL streptomycin, and 10% heat-inactivated foetal bovine serum. Cells were placed in completely filled 50 mL vessels, to avoid the presence of air bubbles that could lead to shear force damage of cells on the RCCS. Vessels were rotated at a speed of 7.2 rpm (simulated microgravity and referred to as sim-μg), as reported [30, 37], or cultured at ground gravity (1 g), as controls. Incubation of 1 g and sim-μg cells with different compounds was performed at 37°C in an atmosphere of 5% CO2, at the indicated concentrations and for the indicated periods of time.
2.3. Evaluation of PCD
PCD was estimated by the cell-death detection enzyme-linked immunosorbent assay (ELISA) kit (Boehringer Mannheim, Germany), based on evaluation of histone-associated DNA fragments in the cytoplasm, as previously reported .
Cytochrome c release from mitochondria was analyzed as reported . Briefly, cells were lysed in HB buffer (5 mM Tris-HCl pH 7.4, 10 mM KCl, 1 mM MgCl2, and 1 mM DTT), containing protease inhibitor cocktail, and centrifuged at 1000 ×g for 10 min to completely remove nuclei and whole cells. The resulting supernatant was centrifuged at 3000 ×g for 10 min; then the pellet was saved as membrane-bound organellar fraction enriched with mitochondria, while the supernatant, after centrifugation at 100000 ×g for 40 min, was collected as cytosolic fraction. These two fractions were analyzed for cytochrome c localization by means of ELISA: mitochondrial and cytosolic proteins (20 μg/well) were incubated with anti-cytochrome c antibody (diluted 1 : 500), and after incubation with a GAR-AP (diluted 1 : 2000), colour development of the alkaline phosphatase reaction was measured at 405 nm , by using -nitrophenyl phosphate as substrate.
2.4. Analysis of μ-Calpain Activity and Expression
Detection of μ-calpain mRNA was performed by quantitative reverse transcriptase-polymerase chain reaction (q-RT-PCR), as previously reported . Briefly, total RNA was extracted from Jurkat cells using the RNeasy extraction kit (Qiagen, Crawley, UK), following the manufacturer’s instructions. RT-PCR reactions were performed using the RT-PCR SuperScript III Platinum Two-Step qRT-PCR Kit (Invitrogen, Carlsbad, CA, USA). One μg total RNA was used to synthesize cDNA with 10 U/μL SuperScript III reverse transcriptase, in the presence of 2 U/μL RNaseOUT, 1.25 μM oligo (dT), 1.25 ng/μL random hexamers, 5 mM MgCl2, 0.5 mM dNTP mix, and DEPC-treated water. The reaction was performed using the following RT-PCR program: 25°C for 10 min, 42°C for 50 min, 85°C for 5 min, and then, after addition of 0.1 U/μL of E. coli RNase H, the product was incubated at 37°C for 20 min. For expression studies, target transcripts were amplified in ABI PRISM 7700 sequence detector system (Applied Biosystems, Foster City, CA, USA). Thermal cycling involved 40 cycles of 95°C for 15 sec and 60°C for 30 sec, after initial denaturation for 10 min at 95°C. TaqMan MGB probe was synthesized by Applied Biosystems (Foster City, CA, USA). The probe was labelled with the fluorescent dye 6-carboxyfluorescein at the 5′ end and a dark quencher at the 3′ end (Applied Biosystems). Fluorescence was measured after each cycle of PCR and, to confirm the quality of isolated RNA and to standardize the amount of RNA applied, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as endogenous control with FAMTM dye label and MGB. Real-time PCR mixtures contained template cDNA, 20x Primer/Probe Mix, TaqMan MGB Probe with FAMTM dye label, no primer limitation, Minor Groove Binder and Nonfluorescent Quencher, Universal PCR Master Mix, no AmpErase UNG Applied Biosystems (Foster City, CA, USA) in a total volume of 25 μL in a 96-well plate. Relative μ-calpain expression levels were measured by CT method (PE-Applied Biosystems; Sequence Detector User Bulletin).
Calpain protein expression was evaluated by Western blot analysis. Briefly, cell lysates (20 μg/well) were subjected to SDS-PAGE, electroblotted onto PVDF membranes, incubated with mouse anti-μ-calpain antibody (1 : 4000), which detects both the full-length (large subunit) and the autoproteolytically cleaved forms of μ-calpain, and detected with ECL. Calpain quantification was also evaluated through ELISA method, by incubating protein lysates (20 μg/well) with mouse anti-μ-calpain-1 (1 : 2000) as primary antibody and HRP-conjugated antibody (1 : 5000) as secondary antibody. The HRP enzymatic activity was determined by adding 100 μL/well of tetramethylbenzidine containing 0.002% H2O2, and the absorbance was read on a microplate reader (ELISA Ascent Software per Multiskan) at 450 nm. Absorbance values of the samples were within the linearity range of the ELISA test, assessed by calibration curves with known amounts of μ-calpain (in the range of 7.5–60.0 ng/well).
The enzymatic activity of μ-calpain was measured as reported . Briefly, cell lysates (40 μg/test) were incubated with 150 μM calpain substrate (N-Suc-Leu-Tyr-AMC) in 10 mM Hepes, pH 7.4, 1% Triton X-100, and 100 μM CaCl2, for 2 hours at 37°C. After incubation, hydrolyzed AMC groups were measured on a fluorimeter LS50B (Perkin-Elmer Life Sciences Inc., Boston, MA, USA) with an excitation filter of 380 nm and emission filter of 460 nm.
2.5. 5-LOX Activity
The activity of 5-LOX (arachidonate:oxygen 5-oxidoreductase; E.C. 22.214.171.124) was determined as previously reported . Briefly, the end product leukotriene (LT) B4 was extracted from Jurkat cells (5 106 cell/test) and quantified at 405 nm by using the Leukotriene B4 EIA Kit (Cayman Chemical Company, Ann Arbor, MA, USA) and calibration curves drawn according to the customer’s instructions.
2.6. Cytokine Profile Analysis
Jurkat cells harvested after 48 hours were centrifuged at 200 ×g for 10 min to collect cells and culture medium. Cells were lysed in 50 mM Tris-HCl (pH 7.4), containing protease inhibitors, and cytokine content was quantified by coating proteins (20 μg/well) from whole lysates overnight in a 96-well ELISA microplate, as reported . Rabbit anti-LIF, anti-IL-2, anti-IL-4, anti-IL-6, anti-IL-10, and anti-INFγ (diluted 1 : 500) were used as primary antibodies; GAR-AP (diluted 1 : 2000) was used as secondary antibody and absorbance values were read at 405 nm. Release of LIF and other cytokines from Jurkat cells into the medium was quantified through Quantikine Immunoassay kit (R&D System, Minneapolis, MN, USA) and a specific Multiprotein Profiling ELISA Kit (SuperArray Bioscience Co., Germany), respectively, according to the manufacturer’s instructions. To this aim, 50 μL of culture medium was used, and the content of each protein was evaluated by comparing values to those of antigen standard curves (positive controls).
2.7. Statistical Analysis
All values were expressed as means ± SEM of at least three independent experiments. Student’s unpaired -test or one-way ANOVA (followed by Bonferroni post hoc analysis) was used to compare quantitative data with normal distributions and equal variance. The statistical InStat 3 program (GraphPAD Software for Science, San Diego, California) was used, and a value of was considered statistically significant.
3.1. Prolonged Exposure to Simulated Microgravity Induces Apoptosis in Human Jurkat T Cells
Jurkat T cells were exposed to simulated microgravity for different times (from 0 to 48 hours) and the hallmarks of apoptosis DNA fragmentation and cytochrome c release were analyzed. In agreement with previously reported data , RCCS treatment led to a time-dependent increase of cytosolic DNA fragments that were undetectable after a brief exposure (4 hours) to simulated microgravity, increased after 24 hours (~2-fold over 1 g cells), and reached a maximum level of ~3-fold over controls 24 hours later (Table 1). Then, the subcellular localization of cytochrome c upon simulated microgravity was checked. Jurkat cells exposed to weightlessness showed a loss of mitochondrial cytochrome c and a parallel increase in the cytosolic content, with a time-dependence comparable to that observed for DNA fragmentation (Table 1). Conversely, Jurkat cells incubated at 1 g under the same experimental conditions did not show significant signs of PCD (Table 1). Since RCCS treatment for 48 hours yielded a significant increase in PCD, we chose to perform all subsequent experiments using this time point.
|Results are expressed as percentage of 1g cells set to 100. For DNA fragmentation, 100% = 0.300 0.030 A405 nm; for cytochrome c release, 100% = 0.074 0.005. denotes 0.01 versus 1g cells; denotes 0.001 versus 1g cells.|
3.2. Prolonged Exposure to Simulated Microgravity Upregulates μ-Calpain Expression and Activity in Human Jurkat T Cells
We have previously reported that after 48 hours of exposure to authentic microgravity, human lymphocytes show increased mRNA levels of μ-calpain , a Ca2+-dependent intracellular cysteine protease that is implicated in different physiological functions, including cell growth and apoptosis . Therefore, once established that under our experimental conditions Jurkat cells underwent apoptosis, we checked whether RCCS treatment might engage μ-calpain. In agreement with our previous data , RT-qPCR experiments demonstrated a significant increase of μ-calpain mRNA in sim-μg Jurkat cells (~2-fold over 1 g cells) (Figure 1(a)). Interestingly, upregulation of capn 1 gene, which encodes μ-calpain, was paralleled by increased protein content (Figures 1(b) and 1(c)). Western blot analysis, indeed, showed that 48 hours of RCCS treatment dramatically increased μ-calpain protein levels; in particular, larger amounts of autocleaved and active fragment of μ-calpain (~75 kDa)  were found in sim-μg, whereas no active enzyme was observed in 1 g cells (Figure 1(b)). Such a result was further corroborated by ELISA, revealing that RCCS almost doubled μ-calpain protein content after 48 hours (Figure 1(c)). We next determined whether increased mRNA and protein content might result in increased enzyme activity. By analysing the cleavage of a fluorogenic μ-calpain substrate, we observed an enhanced protease activity in sim-μg T cells (~2-fold over 1 g cells) (Figure 1(d)). Specific proteolytic activity of calpain was confirmed by the addition of 5 μM calpastatin (Figure 1(d)), the natural calpain inhibitor . Since calpain activation seemed to be implicated in DNA fragmentation [44, 45], we analyzed the effect of E64D, a cell permeable and selective inhibitor of the same protease , on simulated microgravity-induced PCD. As shown in Figure 1(e), inhibition of calpain activity significantly lowered internucleosomal DNA fragmentation, thus preventing weightlessness-induced cell death of T cells.
3.3. Prolonged Exposure to Simulated Microgravity Affects the Balance between Proapoptotic and Antiapoptotic Cytokines in Jurkat Cells
Then, we characterized the cytokine profile in Jurkat T cells exposed to simulated microgravity. As demonstrated by ELISA assay, 48 hours of RCCS treatment significantly reduced the synthesis and release of antiapoptotic cytokines like LIF, IL-4, and IL-2, while increasing protein levels of the proapoptotic cytokine INF-γ (Figure 2). Instead, no change in IL-6 and IL-10 content was observed upon simulated microgravity treatment (Figure 2).
Next, we went further by investigating whether RCCS-induced PCD might be related to the unbalance between proapoptotic and antiapoptotic cytokines. To this aim, we analyzed apoptosis in Jurkat cells cultured under simulated microgravity for 48 hours, in the presence of the cytokines that changed upon RCCS exposure. Neither LIF nor IL-4 (both at 10 ng/mL) reduced cytosolic DNA fragments (Figure 3(a)) and cytochrome c content (Figure 3(b)); on the other hand, 10 ng/mL IL-2 was able to protect Jurkat cells from simulated microgravity-triggered cell death, since it significantly reduced both DNA fragmentation and cytochrome c release (Figures 3(a) and 3(b)). To validate our hypothesis, we also analyzed the effect of INF-γ (10 ng/mL). In agreement with the previous data (Figure 2), the latter cytokine drastically enhanced RCCS-induced PCD of Jurkat cells (~ 4.5- and 2.5-fold over 1 g cells and sim-μg cells, resp.) (Figures 3(a) and 3(b)).
To gain further insights on the evaluation of a possible relationship between altered IL-2/INF-γ content and calpain activation, we measured the activity of the latter enzyme in the presence of these two cytokines. Interestingly, IL-2 reduced calpain activation due to simulated microgravity, while INF-γ did not significantly affect enzyme activity (Figure 3(c)).
3.4. Effect of Inhibition of μ-Calpain and 5-LOX on Apoptosis and Cytokine Release
Since we observed that simulated microgravity triggers apoptosis by altering the content of IL-2 and INF-γ, we asked whether such an event might engage 5-LOX, which has been proposed as a “gravity responder” . First, we analyzed 5-LOX activity by quantifying the content of its LTB4 product upon RCCS exposure. In agreement with previous data, we found an early increase of 5-LOX activity (~2 fold over 1 g cells), with values that remained unchanged over the whole time period tested (Table 2). Hence, we subjected Jurkat cells to simulated microgravity in the presence of 10 μM AA861, a specific 5-LOX inhibitor . As shown in Table 3, we observed that 5-LOX inhibition reduced DNA fragmentation and cytochrome c release and reverted calpain activation. More interestingly, it was able to restore the balance between IL-2/and INF-γ that was altered by RCCS treatment. These data seem to suggest that increased 5-LOX activity might be (at least in part) responsible for altered cytokine levels.
|100% of 5-LOX activity = 89 ± 7 pg of LTB4/1 106 cells. denotes < 0.01 versus 1g cells.|
|Values are reported as percentage of relative control set to 100. For DNA fragmentation, 100% = 0.30 ± 0.03 A405 nm; for cytochrome c release, 100% = 0.074 ± 0.005; for calpain activity, 100% = 66.26 ± 3.65 pmol/min per mg protein; for IL-2 synthesis, 100% = 0.27 0.01 A405 nm; for INF- synthesis, 100% = 0.25 ± 0.02 A405 nm. denotes = < 0.05 versus 1g cells; denotes < 0.01 versus 1g cells; denotes < 0.001 versus 1g cells; denotes < 0.01 versus sim-g cells.|
The effects of LTs on the secretion of cytokines have been reported both in vitro and in vivo . Here, we demonstrated that increased LTB4 synthesis upon simulated microgravity exposure is paralleled by a reduced release of antiapoptotic cytokines, such as LIF, IL-4, and IL-2 [19–23], as well as by a significant increase of the production of the proapoptotic cytokine INF-γ [18, 23]. These data are in line with the immunomodulatory role postulated for 5-LOX metabolites, and especially for LTB4. Indeed, the latter substance is a powerful chemoattractant for inflammatory cells and induces degranulation, superoxide anion production, and adherence of neutrophils to vascular endothelial cells . LTB4 has been already demonstrated to affect the production of several cytokines, including IL-1β [49, 50], IL-2 [51, 52], IL-6 , INF-γ , IL-4 , and IL-10 . Moreover, LTB4 has been also demonstrated to modulate the expression of the IL-2 receptor β-chain in natural killer cells and in CD8+ lymphocytes .
In this context, our data add further information on the mechanism of PCD activation, suggesting a crosstalk between 5-LOX and μ-calpain signalling. In particular, we demonstrate that exposure of Jurkat T cells to simulated microgravity induced activation of μ-calpain and 5-LOX. Our results suggest that the functional interplay between these two enzymes could be related to the synthesis of a specific pattern of cytokines. In line with this, our results show that 5-LOX inhibition (i) reduced DNA fragmentation and cytochrome c release (typical apoptotic markers); (ii) reestablished the initial IL-2/INF-γ ratio; and (iii) more importantly reverted μ-calpain activation induced by simulated microgravity (Table 3). Furthermore, we showed that treatment of Jurkat T cell with IL-2, whose levels are downregulated upon simulated microgravity exposure (Figure 2), significantly reduced μ-calpain activation upon RCCS treatment. Remarkably, the latter result is in agreement with the well-known antiapoptotic effect of IL-2 [21, 23]. It should be noted that the lack of any increase in μ-calpain activity in the presence of 5-LOX inhibitors might be suggestive that additional and as-yet-unknown 5-LOX products are able to directly activate μ-calpain. Thus, in addition to a specific role of distinct cytokines in modulating the crosstalk between 5-LOX and μ-calpain, we can speculate that 5-LOX activation could also induce the formation of specific lipid hydroperoxides that could trigger PCD via μ-calpain activation. In line with the latter hypothesis, hydroperoxides of cardiolipin and phosphatidylserine have been detected as byproducts upon PCD . Consistently, it has been demonstrated that LOX-induced lipid peroxidation triggers AIF-mediated PCD . Indeed, although a finely regulated lipid peroxidation may have beneficial effects for the cells and the whole organism, leading to different physiological roles of LOXs (such as eicosanoid synthesis, cell maturation, and lipid mobilization), when the lipid bilayer of biological membranes is oxidized in an uncontrolled manner (as in the case of external stimuli like microgravity), it may lose its barrier function and thus harm the integrity of subcellular organelles or of the whole cell . Consistently, an overactivated 5-LOX can open pore-like structures in mitochondrial membranes [60, 61], thus forming the basis for a converging role of this enzyme in the induction of PCD by unrelated stimuli .
Overall, our results demonstrate that simulated microgravity-dependent increase in 5-LOX activity regulates survival and cytokine release of human T lymphocytes by engaging μ-calpain.
Our findings seem to add biochemical support to the immunodepression observed in astronauts exposed to authentic microgravity for long periods of time (e.g., International Space Station crew members or astronauts travelling to Mars). Taking into account that Jurkat E6.1 cells are somewhat different from normal human T cells , nonetheless, they are considered a valid experimental model, especially in the light of their exaggerated signaling, making changes much easier to detect. Therefore, only authentic space conditions will give a conclusive answer on whether or not the unbalance between proapoptotic and antiapoptotic cytokines due to impaired 5-LOX and μ-calpain activities can affect immune response, helping to design countermeasures against apoptosis observed in space.
|RCCS:||Rotary cell culture system|
|ELISA:||Enzyme-linked immunosorbent assay|
|GAR-AP:||Goat anti-rabbit conjugated to alkaline phosphatase|
|1 g:||Ground gravity|
|LIF:||Leukaemia inhibitory factor|
|PCD:||Programmed cell death|
|q-RT-PCR:||Quantitative reverse transcriptase-polymerase chain reaction|
|TNF-β:||Tumor necrosis factor-β.|
Conflict of Interests
The authors declare that there is no conflict of interests.
This investigation was supported under contracts from “Disturbi del Controllo Motorio e Cardiorespiratorio” and “From Molecules to Man,” 2006–2009, to Mauro Maccarrone.
- R. M. Baevsky, V. M. Baranov, I. I. Funtova et al., “Autonomic cardiovascular and respiratory control during prolonged spaceflights aboard the International Space Station,” Journal of Applied Physiology, vol. 103, no. 1, pp. 156–161, 2007.
- L. C. Shackelford, “Musculoskeletal response to space flight,” in Principles of Clinical Medicine for Space Flight, M. R. Barratt and S. L. Pool, Eds., pp. 293–306, Springer Science and Business Media, New York, NY, USA, 2008.
- J. H. Keyak, A. K. Koyama, A. LeBlanc, Y. Lu, and T. F. Lang, “Reduction in proximal femoral strength due to long-duration spaceflight,” Bone, vol. 44, no. 3, pp. 449–453, 2009.
- E. Wang, “Age-dependent atrophy and microgravity travel: what do they have in common?” The FASEB Journal, vol. 13, no. 8, pp. S167–S174, 1999.
- D. Williams, A. Kuipers, C. Mukai, and R. Thirsk, “Acclimation during space flight: effects on human physiology,” Canadian Medical Association Journal, vol. 180, no. 13, pp. 1317–1323, 2009.
- N. Battista, M. A. Meloni, M. Bari et al., “5-Lipoxygenase-dependent apoptosis of human lymphocytes in the International Space Station: data from the ROALD experiment,” The FASEB Journal, vol. 26, no. 5, pp. 1791–1798, 2012.
- N. Guéguinou, C. Huin-Schohn, M. Bascove et al., “Could spaceflight-associated immune system weakening preclude the expansion of human presence beyond Earth's orbit?” Journal of Leukocyte Biology, vol. 86, no. 5, pp. 1027–1038, 2009.
- J. Pietsch, J. Bauer, M. Egli et al., “The effects of weightlessness on the human organism and mammalian cells,” Current Molecular Medicine, vol. 11, no. 5, pp. 350–364, 2011.
- B. E. Crucian, R. P. Stowe, D. L. Pierson, and C. F. Sams, “Immune system dysregulation following short- vs long-duration spaceflight,” Aviation Space and Environmental Medicine, vol. 79, no. 9, pp. 835–843, 2008.
- B. Crucian, R. Stowe, S. Mehta et al., “Immune system dysregulation occurs during short duration spaceflight on board the space shuttle,” Journal of Clinical Immunology, vol. 33, no. 2, pp. 456–465, 2013.
- B. S. Crucian, S. R. Zwart, S. Mehta et al., “Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight,” Journal of Interferon & Cytokine Research, 2014.
- S. K. Chapes, S. J. Simske, A. D. Forsman, T. A. Bateman, and R. J. Zimmerman, “Effects of space flight and IGF-1 on immune function,” Advances in Space Research, vol. 23, no. 12, pp. 1955–1964, 1999.
- S. K. Chapes, S. J. Simske, G. Sonnenfeld, E. S. Miller, and R. J. Zimmerman, “Effects of spaceflight and PEG-IL-2 on rat physiological and immunological responses,” Journal of Applied Physiology, vol. 86, no. 6, pp. 2065–2076, 1999.
- A. T. Ichiki, L. A. Gibson, T. L. Jago et al., “Effects of spaceflight on rat peripheral blood leukocytes and bone marrow progenitor cells,” Journal of Leukocyte Biology, vol. 60, no. 1, pp. 37–43, 1996.
- Z. Allebban, A. T. Ichiki, L. A. Gibson, J. B. Jones, C. C. Congdon, and R. D. Lange, “Effects of spaceflight on the number of rat peripheral blood leukocytes and lymphocyte subsets,” Journal of Leukocyte Biology, vol. 55, no. 2, pp. 209–213, 1994.
- D. S. Gridley, J. M. Slater, X. Luo-Owen et al., “Spaceflight effects on T lymphocyte distribution, function and gene expression,” Journal of Applied Physiology, vol. 106, no. 1, pp. 194–202, 2009.
- K. Felix, K. Wise, S. Manna et al., “Altered cytokine expression in tissues of mice subjected to simulated microgravity,” Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 79–85, 2004.
- S. P. Tu, M. Quante, G. Bhagat et al., “IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis,” Cancer Research, vol. 71, no. 12, pp. 4247–4259, 2011.
- D. Duval, B. Reinhardt, C. Kedinger, and H. Boeuf, “Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival,” The FASEB Journal, vol. 14, no. 11, pp. 1577–1584, 2000.
- H. Slaets, D. Dumont, J. Vanderlocht et al., “Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3,” Proteomics, vol. 8, no. 6, pp. 1237–1247, 2008.
- L. R. Devireddy and M. R. Green, “Transcriptional program of apoptosis induction following interleukin 2 deprivation: identification of RC3, a calcium/calmodulin binding protein, as a novel proapoptotic factor,” Molecular and Cellular Biology, vol. 23, no. 13, pp. 4532–4541, 2003.
- L. M. Minter and B. A. Osborne, “Notch and the survival of regulatory T cells: location is everything!,” Science Signaling, vol. 5, no. 234, article pe31, 2012.
- F. C. H. Pinto, G. B. Menezes, S. A. L. Moura, G. D. Cassali, M. M. Teixeira, and D. C. Cara, “Induction of apoptosis in tumor cells as a mechanism of tumor growth reduction in allergic mice,” Pathology Research and Practice, vol. 205, no. 8, pp. 559–567, 2009.
- M.-J. Xie, Y.-G. Ma, F. Gao et al., “Activation of BKCa channel is associated with increased apoptosis of cerebrovascular smooth muscle cells in simulated microgravity rats,” American Journal of Physiology: Cell Physiology, vol. 298, no. 6, pp. C1489–C1500, 2010.
- D. Grimm, J. Bauer, P. Kossmehl et al., “Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells,” The FASEB Journal, vol. 16, no. 6, pp. 604–606, 2002.
- C. Y. Kang, L. Zou, M. Yuan et al., “Impact of simulated microgravity on microvascular endothelial cell apoptosis,” European Journal of Applied Physiology, vol. 111, no. 9, pp. 2131–2138, 2011.
- B. M. Uva, M. A. Masini, M. Sturla et al., “Microgravity-induced apoptosis in cultured glial cells,” European Journal of Histochemistry, vol. 46, no. 3, pp. 209–214, 2002.
- L. H. Yan, Z. Hong, M. G. Ying et al., “Simulated microgravity conditions and carbon ion irradiation induce spermatogenic cell apoptosis and sperm DNA damage,” Biomedical and Environmental Sciences, vol. 26, no. 9, pp. 726–734, 2013.
- B. Dang, Y. Yang, E. Zhang et al., “Simulated microgravity increases heavy ion radiation-induced apoptosis in human B lymphoblasts,” Life Sciences, vol. 97, no. 2, pp. 123–128, 2014.
- M. Maccarrone, N. Battista, M. Meloni et al., “Creating conditions similar to those that occur during exposure of cells to microgravity induces apoptosis in human lymphocytes by 5-lipoxygenase-mediated mitochondrial uncoupling and cytochrome c release,” Journal of Leukocyte Biology, vol. 73, no. 4, pp. 472–481, 2003.
- A. Seiler, M. Schneider, H. Förster et al., “Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death,” Cell Metabolism, vol. 8, no. 3, pp. 237–248, 2008.
- M.-S. Lee, Y. T. Kwon, M. Li, J. Peng, R. M. Friedlander, and L.-H. Tsai, “Neurotoxicity induces cleavage of p35 to p25 by calpain,” Nature, vol. 405, no. 6784, pp. 360–364, 2000.
- D. Guerini, B. Pan, and E. Carafoli, “Expression, purification, and characterization of isoform 1 of the plasma membrane Ca2+ pump: Focus on calpain sensitivity,” The Journal of Biological Chemistry, vol. 278, no. 40, pp. 38141–38148, 2003.
- H.-Y. Wu, K. Tomizawa, Y. Oda et al., “Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration,” The Journal of Biological Chemistry, vol. 279, no. 6, pp. 4929–4940, 2004.
- B. M. Polster, G. Basańez, A. Etxebarria, J. M. Hardwick, and D. G. Nicholls, “Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria,” Journal of Biological Chemistry, vol. 280, no. 8, pp. 6447–6454, 2005.
- S. A. Susin, H. K. Lorenzo, N. Zamzami et al., “Molecular characterization of mitochodrial apoptosis-inducing factor,” Nature, vol. 397, no. 6718, pp. 441–446, 1999.
- R. Mitteregger, G. Vogt, E. Rossmanith, and D. Falkenhagen, “Rotary cell culture system (RCCS): a new method for cultivating hepatocytes on microcarriers,” The International Journal of Artificial Organs, vol. 22, no. 12, pp. 816–822, 1999.
- M. V. Catani, V. Gasperi, D. Evangelista, A. F. Agrò, L. Avigliano, and M. MacCarrone, “Anandamide extends platelets survival through CB1-dependent Akt signaling,” Cellular and Molecular Life Sciences, vol. 67, no. 4, pp. 601–610, 2010.
- K. G. Daniel, J. S. Anderson, Q. Zhong, A. Kazi, P. Gupta, and Q. P. Dou, “Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis,” International Journal of Molecular Medicine, vol. 12, no. 2, pp. 247–252, 2003.
- V. Gasperi, F. Fezza, N. Pasquariello et al., “Endocannabinoids in adipocytes during differentiation and their role in glucose uptake,” Cellular and Molecular Life Sciences, vol. 64, no. 2, pp. 219–229, 2007.
- P. Łopatniuk and J. M. Witkowski, “Conventional calpains and programmed cell death,” Acta Biochimica Polonica, vol. 58, no. 3, pp. 287–296, 2011.
- H. Sorimachi, S. Ishiura, and K. Suzuki, “Structure and physiological function of calpains,” Biochemical Journal, vol. 328, article 3, pp. 721–732, 1997.
- T. Uemori, T. Shimojo, K. Asada et al., “Characterization of a functional domain of human calpastatin,” Biochemical and Biophysical Research Communications, vol. 166, no. 3, pp. 1485–1493, 1990.
- J. Takano, M. Tomioka, S. Tsubuki et al., “Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice,” The Journal of Biological Chemistry, vol. 280, no. 16, pp. 16175–16184, 2005.
- A. Rami, R. Agarwal, G. Botez, and J. Winckler, “μ-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage,” Brain Research, vol. 866, no. 1-2, pp. 299–312, 2000.
- Y. Yang, Z. H. Liu, C. F. Ware, and J. D. Ashwell, “A cysteine protease inhibitor prevents activation-induced T-cell apoptosis and death of peripheral blood cells from human immunodeficiency virus-infected individuals by inhibiting upregulation of Fas ligand,” Blood, vol. 89, no. 2, pp. 550–557, 1997.
- Y. Tanihiro, Y. Chieko, O. Kenkichi et al., “2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-l,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis,” Biochimica et Biophysica Acta: Lipids and Lipid Metabolism, vol. 713, no. 2, pp. 470–473, 1982.
- J. C. Eun, E. E. Moore, A. Banerjee et al., “Leukotriene B4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells,” Shock, vol. 35, no. 3, pp. 240–244, 2011.
- G. Bonizzi, J. Piette, M. P. Merville, and V. Bours, “Distinct signal transduction pathways mediate nuclear factor- κB induction by IL-1beta in epithelial and lymphoid cells,” Journal of Immunology, vol. 159, no. 11, pp. 5264–5272, 1997.
- J. Marcinkiewicz, A. Grabowska, K. Bryniarski, and B. M. Chain, “Enhancement of CD4+ T-cell-dependent interleukin-2 production in vitro by murine alveolar macrophages: the role of leukotriene B4,” Immunology, vol. 91, no. 3, pp. 369–374, 1997.
- M. Los, H. Schenk, K. Hexel, P. A. Baeuerle, W. Droge, and K. Schulze-Osthoff, “IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase,” The EMBO Journal, vol. 14, no. 15, pp. 3731–3740, 1995.
- J. Dornand, C. Sekkat, J.-C. Mani, and M. Gerber, “Lipoxygenase inhibitors suppress IL-2 synthesis: relationship with rise of [Ca++]i and the events dependent on protein kinase C activation,” Immunology Letters, vol. 16, no. 2, pp. 101–106, 1987.
- M. A. Brach, S. de Vos, C. Arnold, H.-J. Gruß, R. Mertelsmann, and F. Herrmann, “Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-NB and NF-IL6,” European Journal of Immunology, vol. 22, no. 10, pp. 2705–2711, 1992.
- H. M. Johnson and B. A. Torres, “Leukotrienes: Positive signals for regulation of γ-interferon production,” Journal of Immunology, vol. 132, no. 1, pp. 413–416, 1984.
- N. Dugas, B. Dugas, J.-P. Kolb, K. Yamaoka, J. F. Delfraiss, and C. Damais, “Role of leukotriene B4 in the interleukin-4-induced human mononuclear phagocyte activation,” Immunology, vol. 88, no. 3, pp. 384–388, 1996.
- S. Jozefowski, R. Biedroń, M. Bobek, and J. Marcinkiewicz, “Leukotrienes modulate cytokine release from dendritic cells,” Immunology, vol. 116, no. 4, pp. 418–428, 2005.
- J. Stankova, N. Gagnon, and M. Rola-Pleszczynski, “Leukotriene B4 augments interleukin-2 receptor-beta (IL-2Rβ) expression and IL-2Rβ-mediated cytotoxic response in human peripheral blood lymphocytes,” Immunology, vol. 76, no. 2, pp. 258–263, 1992.
- V. E. Kagan, V. A. Tyurin, J. Jiang et al., “Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors,” Nature Chemical Biology, vol. 1, no. 4, pp. 223–232, 2005.
- M. Maccarrone, G. Melino, and A. Finazzi-Agrò, “Lipoxygenases and their involvement in programmed cell death,” Cell Death and Differentiation, vol. 8, no. 8, pp. 776–784, 2001.
- K. van Leyen, R. M. Duvoisin, H. Engelhardt, and M. Wiedmann, “A function for lipoxygenase in programmed organelle degradation,” Nature, vol. 395, no. 6700, pp. 392–395, 1998.
- R. R. Bartelt, N. Cruz-Orcutt, M. Collins, and J. C. D. Houtman, “Comparison of T cell receptor-induced proximal signaling and downstream functions in immortalized and primary T cells,” PLoS ONE, vol. 4, no. 5, Article ID e5430, 2009.
Copyright © 2014 Valeria Gasperi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.